top
Search terms
Results 1 - 5 of 5 - ordered by :
Ehjournal

New biomarkers might be of additional value to detect an early deterioration in renal function and to improve the prognostic assessment, but they need further validation. [...]the evaluation of ...

European Heart Journal, Metra, Marco, Cotter, Gad, Gheorghiade, Mihai, Dei Cas, Livio, Voors, Adriaan A.

Date : 01/09/2012
Ehjournal

Despite the high prevalence, mortality, and cost of HF-PEF, large phase III international clinical trials investigating interventions to improve outcomes in HF-PEF have yielded disappointing ...

European Heart Journal, Senni, Michele, Paulus, Walter J., Gavazzi, Antonello, Fraser, Alan G., Díez, Javier, Solomon, Scott D., Smiseth, Otto A., Guazzi, Marco, Lam, Carolyn S. P., Maggioni, Aldo ...

Date : 21/10/2014 Item size : 826418 bytes
Ehjournal

Methods and results Of the 4133 patients hospitalized with worsening HF and reduced left ventricular ejection fraction (LVEF) (40%) in the EVEREST trial, 2072 were randomized to tolvaptan, a ...

European Heart Journal, Blair, John E.A., Pang, Peter S., Schrier, Robert W., Metra, Marco, Traver, Brian, Cook, Thomas, Campia, Umberto, Ambrosy, Andrew, Burnett, John C., Grinfeld, Liliana, ...

Date : 01/10/2011 Item size : 327049 bytes
Ehjournal

Despite the high prevalence, mortality, and cost of HF-PEF, large phase III international clinical trials investigating interventions to improve outcomes in HF-PEF have yielded disappointing ...

European Heart Journal, Senni, Michele, Paulus, Walter J., Gavazzi, Antonello, Fraser, Alan G., Díez, Javier, Solomon, Scott D., Smiseth, Otto A., Guazzi, Marco, Lam, Carolyn S. P., Maggioni, Aldo ...

Date : 21/10/2014
Ehjournal

New biomarkers might be of additional value to detect an early deterioration in renal function and to improve the prognostic assessment, but they need further validation. [...]the evaluation of ...

European Heart Journal, Metra, Marco, Cotter, Gad, Gheorghiade, Mihai, Dei Cas, Livio, Voors, Adriaan A.

Date : 01/09/2012